Alice Zhang, founder and CEO of Verge Genomics

Al­ice Zhang's 'all-in-hu­man' AI and ge­nomics up­start scores a $98M Se­ries B

Just a few months af­ter Cal­i­for­nia AI and ge­nomics play­er Verge Ge­nomics part­nered with Eli Lil­ly in a $700 mil­lion-plus biobucks deal for 4 neu­ro­log­i­cal pro­grams, the biotech has fin­ished rais­ing its next fi­nanc­ing round — net­ting $98 mil­lion in eq­ui­ty fund­ing with Lil­ly jump­ing on board as a new in­vestor.

The South San Fran­cis­co-based, neu­ro­science-fo­cused com­pa­ny an­nounced the com­ple­tion of the Se­ries B this morn­ing, which was led by Black­Rock-man­aged funds and sup­port­ed by some new big-name in­vestors such as Eli Lil­ly, Mer­ck’s Glob­al Health In­no­va­tion Fund and Vul­can Cap­i­tal. Some ex­ist­ing in­vestors joined in as well, in­clud­ing ALS In­vest­ment Fund and Tao Cap­i­tal Part­ners.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.